Amgen (AMGN) has found no material impact on its financial condition or operations following a cybersecurity breach, the company said Friday in a filing.
The drugmaker identified unauthorized activity this month involving data stored in cloud systems operated by third- party providers. The incident resulted in the exfiltration of some company data, including patient and proprietary information, it said.
Amgen continues to assess the potential impact of the incident and is reviewing its regulatory and legal notification requirements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments